An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver Diseases.

An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver Diseases.
复制标题

DOI:
10.1002/hep.24641
复制
发表时间:
2011-10
期刊:
影响因子:
13.5
通讯作者:
Seeff, Leonard B.
Seeff, Leonard B.
中科院分区:
医学1区
文献类型:
--
作者:
Ghany, Marc G.;Nelson, David R.;Strader, Doris B.;Thomas, David L.;Seeff, Leonard B.

文献摘要

参考文献

被引文献

相似文献

设计实践指南;1(3)指南政策,包括AASLD关于制定和使用实践指南的政策和美国胃肠病协会关于使用医疗实践指南的政策声明;2和(4)作者在丙型肝炎方面的经验。这些建议旨在供医生使用,这些建议建议了诊断、治疗和预防方面的首选方法。它们的目的是灵活的,与护理标准形成对比,后者是在任何情况下都要遵循的僵化政策。具体建议以已公布的相关信息为基础。为了更全面地描述支持建议的证据的质量,AASLD的实践指南委员会要求在每个建议中分配和报告一类(反映益处与风险)和水平(评估强度或确定性)的证据(表1,改编自美国心脏病学会和美国心脏协会实践指南)。3、4
Designing Practice Guidelines; 1 (3) guideline policies, including the AASLD Policy on the Development and Use of Practice Guidelines and the American Gastroenterological Association’s Policy Statement on the Use of Medical Practice Guidelines; 2 and (4) the experience of the authors in regard to hepatitis C. Intended for use by physicians, these recommendations suggest preferred approaches to the diagnostic, therapeutic, and preventive aspects of care. They are intended to be flexible, in contrast to standards of care, which are inflexible policies to be followed in every case. Specific recommendations are based on relevant published information. To more fully characterize the quality of evidence supporting recommendations, the Practice Guidelines Committee of the AASLD requires a Class (reflecting benefit versus risk) and Level (assessing strength or certainty) of Evidence to be assigned and reported with each recommendation (Table 1, adapted from the American College of Cardiology and the American Heart Association Practice Guidelines). 3, 4
DOI: 10.1053/j.gastro.2010.05.079
发表时间: 2010-09-01
期刊: GASTROENTEROLOGY
影响因子: 29.4
作者:
Mangia, Alessandra;Thompson, Alexander J.;Mchutchison, John G.
通讯作者: Mchutchison, John G.
DOI: 10.1056/nejmoa1012912
发表时间: 2011-06-23
影响因子: 158.5
作者:
Jacobson, Ira M.;McHutchison, John G.;Zeuzem, Stefan
通讯作者: Zeuzem, Stefan
DOI: 10.1002/hep.23528
发表时间: 2010-06-01
期刊: HEPATOLOGY
影响因子: 13.5
作者:
Bruno, Savino;Crosignani, Andrea;Maisonneuve, Patrick
通讯作者: Maisonneuve, Patrick
DOI: 10.1016/s0140-6736(10)60934-8
发表时间: 2010-08-01
期刊: LANCET
影响因子: 168.9
作者:
Kwo, Paul Y.;Lawitz, Eric J.;Albrecht, Janice K.
通讯作者: Albrecht, Janice K.
DOI: 10.1056/nejmoa1010494
发表时间: 2011-03-31
期刊: The New England journal of medicine
影响因子: --
作者:
Poordad F;McCone J Jr;Bacon BR;Bruno S;Manns MP;Sulkowski MS;Jacobson IM;Reddy KR;Goodman ZD;Boparai N;DiNubile MJ;Sniukiene V;Brass CA;Albrecht JK;Bronowicki JP;SPRINT-2 Investigators
通讯作者: SPRINT-2 Investigators